Cancer Drug Supplier’s IPO Mints China’s Latest Billionaire | CPT PPP Coverage
Cryptopolytech (CPT) Public Press Pass (PPP)
News of the Day COVERAGE
200000048 – World Newser
•| #World |•| #Online |•| #Media |•| #Outlet |
View more Headlines & Breaking News here, as covered by cryptopolytech.com
Cancer Drug Supplier’s IPO Mints China’s Latest Billionaire appeared on www.forbes.com by Russell Flannery.
A pedestrian walks past the Shanghai Stock Exchange in Shanghai in 2020. (Photo by HECTOR … [+]
Today’s listing at the Shanghai Stock Exchange by Sichuan Biokin Pharmaceutical, a supplier of cancer drugs, has minted China’s latest billionaire.
Chairman Zhu Yi directly owns 298.1 million shares, worth 10 billion yuan, or $1.5 billion in early afternoon trading. Shares rose 36% from their IPO price to 33.69 yuan.
Zhu holds an undergraduate degree in radio technology, as well as a master’s degree in biology from Fudan University and a doctorate in management from Sichuan University. He taught immunology and microbiology at West China Medical University in 1987-1990.
Zhu founded Biokin in 1996. It operates in the U.S. through a Redmond, Washington-based subsidiary, Systimmune. China securities regulators approved Biokin’s IPO in December.
The country and the U.S. rank No. 1 and No. 2 in the number of cancer patients and overall cancer burden. China is home to the world’s second-largest number of billionaires after the United States.
— with Julie Lu
See related posts:
U.S., China Advance Discussions To Accelerate Cancer Drug Trials
China’s Richest See Record Plunge In Wealth
New Questions Arise For U.S. Businesses In China After “Jarring” End To Zero-Covid Policy
@rflannerychina
FEATURED ‘News of the Day’, as reported by public domain newswires.
View ALL Headlines & Breaking News here.
Source Information (if available)
This article originally appeared on www.forbes.com by Russell Flannery – sharing via newswires in the public domain, repeatedly. News articles have become eerily similar to manufacturer descriptions.
We will happily entertain any content removal requests, simply reach out to us. In the interim, please perform due diligence and place any content you deem “privileged” behind a subscription and/or paywall.
CPT (CryptoPolyTech) PPP (Public Press Pass) Coverage features stories and headlines you may not otherwise see due to the manipulation of mass media.
First to share? If share image does not populate, please close the share box & re-open or reload page to load the image, Thanks!